none>HOT wittle one on yesterday news>ABIO:New Adaptive Phase 3 Trial Planned for GencaroTM in Atrial Fibrillation $ .78(08:01:44 AM) $ .4389 (06:50:27 AM) Read more: http://www.nasdaq.com/symbol/abio/premarket#ixzz2JSqRChZN http://finance.yahoo.com/news/adaptive-phase-3-trial-planned-220000121.html